From Safety Testing to Documentation: Building a Drug Master File That Speeds Approval
Published on Dec 2, 2025 Share
Regulatory documentation is often a critical bottleneck on the path from therapeutic discovery to market. Every reagent, buffer, and consumable used in manufacturing must be accounted for, and incomplete records can delay Investigational New Drug (IND) approval.
In cell therapy manufacturing, this is especially true for ancillary materials—the reagents and materials that come into contact with patient-derived cells during isolation, activation, and expansion. Although ancillary materials are not part of the final therapeutic product, they have a direct impact on safety and consistency, and have recommended regulatory compliance actions.
Selecting suppliers with a robust regulatory support system is a strong recommendation to support IND submission and eventual product approval. Akadeum’s quality framework was designed to support compliance and to help developers build confidence in every product they list in their IND or Biologics License Application (BLA).
What Is a Drug Master File?
A Drug Master File (DMF) is a structured package of records that provides the U.S. Food and Drug Administration (FDA) with documentation demonstrating the safety, quality, specifications, testing, and processes for each material used in manufacturing. DMFs typically include information on facilities and equipment, adventitious agents safety evaluations, biocompatibility, manufacturing (including supplier management), control of drug substance (such as specifications, analytical procedures, validation and verification), product overview, reference standards, container closure systems, and stability. Having this document filed with the FDA streamlines IND and BLA processes from a Chemistry Manufacturing and Controls (CMC) perspective, helping regulators verify product manufacturing consistency and safety.
Choose Suppliers That Provide Strong Submission Support
Regulators, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), require manufacturers to maintain full control over all reagents and materials that impact product safety and quality. Selecting a supplier that aligns with these expectations early can save time during IND preparation and provide confidence in materials by already meeting the CMC guidelines.
Here’s what to look for when evaluating suppliers:
- Strong Quality Management System (QMS) with documented, validated processes
- GMP-grade manufacturing practices under controlled conditions with environmental monitoring
- Supplier management program and change control processes
- Material testing inclusive of biocompatibility, extractables, sterility, endotoxin, and viral
- Certificates of Analysis (CoAs) and Certificate of Origin (when applicable)
- Availability of Drug Master File (DMF)
Akadeum’s cell separation kits are produced under a rigorous QMS framework, with validated manufacturing processes and dedicated quality oversight teams that ensure every GMP product lot is fit for use in regulated environments.
Inside Akadeum’s Regulatory Support Framework
In accordance with Akadeum’s QMS, all microbubble-based kits and reagents are manufactured under GMP conditions using validated processes. Each raw material is fully traceable throughout its lifecycle, with clear documentation from supplier qualification through final lot release.
Comprehensive Documentation
Every GMP lot has a corresponding Certificate of Analysis (CoA) that includes release specifications. Internal validation studies, process controls and validation, adventitious agent and safety testing, are documented and retained per document and record control procedures. A formal change control and notification process ensures that any process modifications are validated, reviewed, approved, team training completed, and communicated to customers.
Simplifying Your IND Preparation
IND applications recommend complete, audit-ready documentation for ancillary materials. Akadeum simplifies this with a Drug Master File submitted to the FDA and available via Letter of Authorization. Akadeum’s DMF aligns with the Chemistry, Manufacturing, and Controls (CMC) guidance and standards for Ancillary Materials in Cell and Gene Therapy, such as ISO 20399 and USP <1043>.
What Sets Akadeum Apart
- Built-in compliance. Validated kits and processes, including material receipt, testing, GMP manufacturing, and supplier management program via supplier questionnaires and audits, to reduce regulatory risk.
- Rigorous Attention to Safety and Quality. Every product lot is traceable to its raw materials. Raw materials in manufacturing are qualified, and production includes in-process and release testing, including sterility, endotoxin, and viral (including mycoplasma) testing by well-known third-party firms, as well as functional testing.
- Responsive support. Quality and regulatory teams provide CoAs, CoOs, and a Letter of Authorization for the DMF upon request.
Frequently Asked Questions
What kind of regulatory support does Akadeum provide?
Akadeum provides documentation upon request, including Certificates of Analysis (CoAs), Certificates of Origin (CoO, when applicable), Product Information Files, and Letter of Authorization for the DMF to support IND and BLA submissions with the U.S. FDA. Akadeum invites you to submit supplier questionnaires and schedule an audit with us. Contact us for your global submission needs.
How does Akadeum simplify IND preparation?
Akadeum simplifies IND preparation by having a DMF for BACS™ Microbubbles for Cell Separation filed with the U.S. FDA that aligns with expectations of suppliers in the CMC guidance. Developers can request a Letter of Authorization to reference Akadeum’s DMF in regulatory submissions, reducing documentation preparation time and, ultimately, review time.
What information is included in a Drug Master File?
Akadeum’s DMF aligns with expectations of suppliers as outlined in the FDA’s CMC guidance document. This information is inclusive of facilities and equipment, adventitious agents safety evaluations, biocompatibility, extractables and toxicological report, manufacturing (including supplier management and processes), control of drug substance (such as specifications, analytical procedures, validation and verification), product overview, reference standards, container closure systems, and stability.
Are Akadeum’s products suitable for GMP manufacturing?
Yes. Akadeum offers GMP-grade kits produced under a robust Quality Management System aligned with 21 CFR 820, 210, 211, and 11.
How can I request a Letter of Authorization (LOA) for the Drug Master File?
LOAs can be requested through Akadeum’s Quality Assurance teams. Contact our Support Team to learn more or to submit a documentation request.
Documentation Designed to Accelerate Approval
Akadeum’s quality framework keeps compliance simple, transparent, and ready to support your IND and BLA documentation process. By choosing Akadeum as your partner for ancillary materials, you gain not only high-performance, microbubble-based cell separation, but also a documentation foundation that accelerates IND preparation and supports long-term regulatory success.
→ Explore Akadeum’s Regulatory Support Page to learn how our documentation and quality systems simplify compliance from research through commercialization.